| T1DM | Type 1 Diabetes Mellitus |
| T2DM | Type 2 Diabetes Mellitus |
| IGF1 | Insulin-like growth factor 1 |
| MSC | Mesenchymal stem cell |
| AGE | Advanced glycation end products |
| BMD | Bone mineral density |
| PTH | Parathyroid hormone |
| TNF-α | Tumor necrosis factor alpha |
| RANKL | Receptor activator of nuclear factor kappa-Β ligand |
| RAGE | Receptor for advanced glycation end products |
| MiRNA | MicroRNA |
| DEXA | Dual-energy X-ray absorptiometry |
| FRAX | Fracture Risk Assessment Tool |
| ALP | Alkaline phosphatase |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| ROSBM-MSCs | Reactive oxygen speciesBone marrow (BM) derived MSCs |
| WAT | White adipose tissue |
| HIF-1α HSCDPP-4 | Hypoxia-inducible factor 1-alphaHaematopoietic stem cellDipeptidyl peptidase-4 |
| GLP1 | Glucagon-like peptide 1 |
| GLP1RA | GLP1 receptor analogue |
| SGLT-2 | Sodium glucose cotransporter- 2 |